The Morocco-based healthtech startup DataPathology announced it raised US$1 million, led by Azur Innovation Fund.
The startup’s mission is to address the lack of and delays in cancer diagnosis, particularly in medically underserved countries like those in Africa using technologies such as AI.
Their innovative process involves conducting a biopsy and preparing a tissue sample at the patient’s examination site, digitizing it, and securely and anonymously transferring the digital file to the medical team for diagnosis through a web platform.
Founded in 2020 by Mohammed El Khannoussi and Hicham El Attar, DataPhathology aims to deliver quick and accurate pathological diagnosis for patient care.
On the back of the recently-acquired funds, the startup aspires to expand its network of laboratories in Morocco and Africa and enhance its proprietary capabilities to increase the volume of data processed into its platform.
The startup also raised a US$196,000 round from Witamax a year and a half ago.
Azur Innovation Fund, a public-private investment fund specialized in financing innovative startups in Morocco, continues its commitment to supporting young companies.
After recently investing $1.1 million in PrestaFreedom, a home services platform focused on subscription-based cleaning and other services for individuals, Azur Innovation Fund is now participating in the funding round of another promising startup “DataPathology”.
DataPathology has already established partnerships with international players in digital health and has set up the first digital pathological diagnosis center in Morocco. They have also initiated discussions with African countries that show high potential for improving cancer diagnosis.
If you see something out of place or would like to contribute to this story, check out our Ethics and Policy section.
